PART I Overview We are a clinical stage product discovery company developing products using both natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases, such as diabetic foot infections, or DFI . Bacteriophage or phage are bacterial, species-specific, strain-limited viruses that infect, amplify and kill the target bacteria and are considered inert to mammalian cells. By utilizing proprietary combinations of naturally occur...
Q2 FY2026 — expected 2026-08-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-19 | 2025-12-31 | 0001213900-26-018231 | EDGAR | 81K words |
| 2025-03-25 | 2024-12-31 | 0001013762-25-002283 | EDGAR | — |
| 2024-04-04 | 2023-12-31 | 0001213900-24-030053 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0001213900-23-024122 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001213900-22-016136 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001213900-21-019233 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001213900-20-007405 | EDGAR | — |
| 2019-08-21 | 2019-06-30 | 0001213900-19-016461 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001213900-25-109186 | EDGAR | 25K words |
| 2025-08-13 | 2025-06-30 | 0001213900-25-075328 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001213900-25-044157 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001213900-24-098523 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001213900-24-068981 | EDGAR | — |
| 2024-05-20 | 2024-03-31 | 0001213900-24-045273 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001213900-23-086662 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001213900-23-064926 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001213900-23-039734 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001213900-22-070435 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001213900-22-046257 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001213900-22-025542 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001213900-26-087839 | EDGAR | — |
| 2026-07-28 | 0001213900-26-082025 | EDGAR | — |
| 2026-04-01 | 0001213900-26-038095 | EDGAR | 10K words |
| 2026-03-27 | 0001213900-26-035605 | EDGAR | — |
| 2026-03-19 | 0001213900-26-031587 | EDGAR | — |
| 2026-03-11 | 0001213900-26-026174 | EDGAR | — |
| 2026-03-06 | 0001213900-26-024344 | EDGAR | — |
| 2026-03-02 | 0001213900-26-022301 | EDGAR | — |
| 2026-02-25 | 0001213900-26-020374 | EDGAR | — |
| 2026-02-13 | 0001213900-26-016402 | EDGAR | — |
174 total filings indexed. 144 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001739174 |
| Ticker | PHGE |
| Exchange | NYSE |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.biomx.com |
| Listed | 2019-03-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PHGE (~200 tokens, structured JSON with cryptographic provenance)